Clinical improvement · adults with refractory, moderate‐to‐severe ulcerative colitis
Tacrolimus may leads to higher clinical improvement compared with placebo (low certainty).
1 finding from 1 review
Clinical improvement · Patients with acute pouchitis
It is very uncertain whether rifaximin changes clinical improvement compared with placebo (very low certainty).
1 finding from 1 review
Clinical improvement · Patients with acute pouchitis
It is very uncertain whether lactobacillus GG changes clinical improvement compared with placebo (very low certainty).
1 finding from 1 review
Clinical improvement · Patients with chronic pouchitis
It is very uncertain whether bismuth enema changes clinical improvement compared with placebo (very low certainty).
1 finding from 1 review
Clinical improvement · Patients with chronic pouchitis or ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
Adalimumab showed no clear difference in clinical improvement compared with placebo (low certainty).
1 finding from 1 review
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · patients with induction of remission in ulcerative colitis
Type I Interferons showed no clear difference in clinical improvement compared with placebo (moderate certainty).
1 finding from 1 review
Clinical improvement · Adult patients with active ulcerative colitis
Budesonide MMX® 9 mg showed no clear difference in clinical improvement compared with placebo (moderate certainty).
1 finding from 1 review
Clinical improvement · Adult patients with active ulcerative colitis
Budesonide MMX® 6 mg showed no clear difference in clinical improvement compared with placebo (low certainty).
1 finding from 1 review
Clinical improvement at 12 weeks · patients with induction of remission in ulcerative colitis
Trichuris suis eggs showed no clear difference in clinical improvement at 12 weeks compared with placebo (low certainty).
1 finding from 1 review
Clinical improvement (continuous) · inactive EoE patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement (continuous) · active EoE patients
1 finding from 1 review
Clinical improvement (continuous) · active EoE patients
1 finding from 1 review
Clinical improvement (continuous) · active EoE pediatric patients
1 finding from 1 review
Clinical improvement (continuous) · active EoE patients
1 finding from 1 review
Clinical improvement (continuous) · inactive EoE patients
1 finding from 1 review